At this time, posts about Dongwha Pharm are rapidly increasing on portals and securities communities, with foreign investors tentatively recorded as net buying 9,970 shares today. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals (such as Gas Hwal Myeong Su and Fusidin).


As of 12:30 PM on the 18th, Dongwha Pharm's stock price is 20,450 KRW, up 8.2% from the previous day, with a trading volume of 6,534,744 shares, which is 674.34% of the 5-day average trading volume.


In addition to Dongwha Pharm, posts by investors are also surging for Hyungji Elite (093240), Central Motec (308170), and Sambu Construction (001470).



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing